Onconova Therapeutics Inc

NASDAQ:ONTX  
0.27
0.00 (+0.19%)
Other Pre-Announcement

Onconova Therapeutics Reports Q3 2020 Results

Published: 11/12/2020 21:43 GMT
Onconova Therapeutics Inc (ONTX) - Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update.
Onconova Therapeutics Inc Qtrly Loss per Share $0.03.
Onconova Therapeutics - Expects That Cash & Cash Equivalents Will Be Sufficient to Fund Ongoing Clinical Trials & Business Operations Into Q1 of 2022.
Onconova Therapeutics Inc - Cash and Cash Equivalents As of September 30, 2020 Were $24.2 Million.